OTCMKTS:CVALF Covalon Technologies (CVALF) Stock Price, News & Analysis $1.75 +0.05 (+2.80%) As of 12:25 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesShort InterestBuy This Stock About Covalon Technologies Stock (OTCMKTS:CVALF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Covalon Technologies alerts:Sign Up Key Stats Today's Range$1.73▼$1.7550-Day Range$1.66▼$2.1052-Week Range$1.46▼$3.08Volume200 shsAverage Volume12,276 shsMarket Capitalization$47.89 millionP/E Ratio33.98Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada. Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Stock News HeadlinesCovalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial ResultsAugust 22 at 7:21 AM | theglobeandmail.comCovalon Technologies Ltd. (CVALF) Q3 2025 Earnings Call TranscriptAugust 21, 2025 | seekingalpha.comBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. August 25 at 2:00 AM | Crypto 101 Media (Ad)Covalon Technologies (CVALF) Projected to Post Quarterly Earnings on WednesdayAugust 18, 2025 | americanbankingnews.comCORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial ResultsAugust 14, 2025 | businesswire.comCovalon Technologies to Release Q3 Fiscal 2025 Financial ResultsAugust 14, 2025 | tipranks.comCovalon Technologies to Discuss Q3 Fiscal 2025 Financial ResultsAugust 14, 2025 | tipranks.comCovalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call TranscriptMay 28, 2025 | seekingalpha.comSee More Headlines CVALF Stock Analysis - Frequently Asked Questions How have CVALF shares performed this year? Covalon Technologies' stock was trading at $2.24 on January 1st, 2025. Since then, CVALF shares have decreased by 22.0% and is now trading at $1.7465. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (OTCMKTS:CVALF) released its quarterly earnings results on Wednesday, May, 28th. The company reported $0.01 EPS for the quarter, hitting analysts' consensus estimates of $0.01. The company earned $5.27 million during the quarter, compared to the consensus estimate of $7.67 million. Covalon Technologies had a trailing twelve-month return on equity of 7.79% and a net margin of 7.00%. How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/28/2025Today8/25/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryN/A Current SymbolOTCMKTS:CVALF CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$0.05 Trailing P/E Ratio34.94 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.96 million Net Margins7.00% Pretax Margin10.93% Return on Equity7.79% Return on Assets6.84% Debt Debt-to-Equity RatioN/A Current Ratio8.39 Quick Ratio6.09 Sales & Book Value Annual Sales$22.91 million Price / Sales2.09 Cash Flow$0.10 per share Price / Cash Flow17.32 Book Value$0.74 per share Price / Book2.36Miscellaneous Outstanding Shares27,420,000Free FloatN/AMarket Cap$47.89 million OptionableNot Optionable Beta0.63 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (OTCMKTS:CVALF) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Covalon Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.